BPC-157 vs TB-500
Which research peptide fits your laboratory protocols?
In research contexts, BPC-157 is primarily studied for localized tissue repair — tendon, ligament, gut, and muscle injury models — while TB-500 is examined for systemic wound healing via actin regulation and cell migration. BPC-157 typically shows stronger effects at injection sites; TB-500 distributes systemically. Both are sold strictly for laboratory research purposes only.
Research Disclaimer: All content summarizes publicly available preclinical literature. No claims are made about human efficacy, safety, or therapeutic use. Not for human consumption.
Head-to-Head Comparison
| Attribute | BPC-157 | TB-500 |
|---|---|---|
| Full Name | Body Protection Compound-157 | Thymosin Beta-4 (Fragment) |
| Type | Synthetic pentadecapeptide (15 amino acids) | Synthetic peptide (43 amino acids) |
| Primary Research Focus | Localized tissue repair, cytoprotection | Systemic wound healing, cell migration |
| Mechanism | Inflammatory pathway modulation, fibroblast proliferation, collagen organization | Actin sequestration, endothelial differentiation, neovascularization |
| Tissue Targets | Tendon, ligament, muscle, gut, spinal cord | Wound healing, cardiac, musculoskeletal (systemic) |
| Angiogenesis | Moderate — promotes in select models | Strong — endothelial migration focus |
| Administration | Subcutaneous (local) or oral | Subcutaneous (systemic) |
| Typical Research Dose | 200–500 mcg/day | 2–5 mg twice weekly (loading) |
| Half-Life | Stable in gastric juice; relatively short systemic | Longer half-life; systemic distribution |
| Research Duration | 4–8 weeks typical | 4–8 weeks (loading + maintenance) |
| Oral Bioavailability | Yes — studied in gut models | No — injectable only |
| Stacking Potential | Combines well with TB-500 (Wolverine Stack) | Combines well with BPC-157, GHK-Cu |
When Researchers Study One vs the Other
Choose BPC-157 When Studying:
- • Localized injury models (tendon, ligament, joint)
- • Gut/intestinal repair and protection
- • Oral delivery protocols
- • Targeted inflammation modulation
- • Nerve and spinal injury models
Choose TB-500 When Studying:
- • Systemic wound healing and recovery
- • Broad musculoskeletal repair
- • Cardiac tissue regeneration
- • Cell migration and angiogenesis
- • Multi-site injury protocols
Use Both (Wolverine Stack) When:
Research aims to study complementary localized + systemic tissue repair, maximizing both targeted and broad regenerative signaling. See full Wolverine Stack Guide →
Frequently Asked Questions
Is BPC-157 or TB-500 better for tissue repair research?▼
It depends on the model. BPC-157 excels in localized injury studies (tendon, gut), while TB-500 is preferred for systemic wound healing and cardiac models. Many researchers combine both for comprehensive coverage.
Can they be administered at the same time?▼
In preclinical research, they are frequently co-administered as separate injections in the same session. The Wolverine Stack protocol is the most commonly referenced combination.
Which has more published research?▼
BPC-157 has a larger body of published preclinical literature (100+ PubMed indexed studies). TB-500/Thymosin Beta-4 research is also extensive but more focused on cardiology and wound models.
What purity should I use?▼
Always use ≥99% HPLC-verified peptides with batch-specific COAs for reproducible results. NovaPure Labs includes third-party analysis with every order.